Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Variant Protects People Against Malaria

08.11.2002


An international team of scientists has discovered a novel genetic trait that protects its carriers against the deadliest forms of malaria, while people without the trait are more likely to succumb to its fatal consequences.



This trait -- a mutation or “polymorphism” in the NOS2 gene -- controls the production of nitric oxide, a small chemical that can kill parasites and prevent malaria disease. Results of their study are published in the Nov. 9, 2002, issue of The Lancet.

The genetic variant explains why some people with malaria have only mild symptoms and recover fully, while others develop severe disease that may progress to death, said researchers from the University of Utah, the Durham Veterans Affairs (VA) Medical Center, Duke University Medical Center, the U.S. Centers for Disease Control and Prevention, Tanzania and Kenya.


“Malaria is a worldwide epidemic, affecting twice the population of the United States every year,” said Brice Weinberg, M.D., professor of medicine at the Durham VA and Duke University Medical Centers and principal investigator on the study. “Drug resistance to malaria is rampant, so our ability to artificially duplicate the benefits of this genetic trait would be enormous.”

People with the NOS2 gene variant make higher levels of nitric oxide, and the nitric oxide protects them from the extensive tissue and brain damage normally caused by the malaria parasite, said Dr. Maurine Hobbs, lead author and research assistant professor of internal medicine and human genetics at the University of Utah.

The team’s ultimate goal is to develop a simple treatment that boosts levels of nitric oxide to treat and prevent malaria, a prospect that the researchers say is well within their grasp.

Nitric oxide works by reducing the malaria parasites’ ability to multiply in liver and blood cells, preventing infected red blood cells from adhering to the lining of blood vessels, and decreasing the production of inflammatory chemicals (cytokines) that exacerbate the disease. Thus, it reduces the most deadly effects of malaria, which target the blood and vital organs such as the brain, said Dr. Nick Anstey, associate professor of medicine at the Menzies School for Health Research in Darwin, Australia.

While excessive nitric oxide can be harmful and causes inflammation in diseases such as arthritis, Anstey said that nitric oxide can also be beneficial by protecting against infections and preventing damage to cells and organs.

“Nitric oxide can be extremely useful when it is produced by the right cells, at the right levels, and at the right time,” said Anstey. Interestingly, he noted, the NOS2 gene variant does not prevent malarial infection; it simply renders the malaria parasite less harmful to bodily systems.

In fact, the NOS2 gene variant confers such overwhelming protection that Tanzanian carriers have an 88 percent lower risk of becoming ill with malaria than those without the trait, the study showed. In Kenya, its carriers have a 75 percent lower rate of developing severe malarial anemia. The two groups of patients consisted of 1,291 children who lived in highly mosquito- and malaria-infested areas of the two countries. The researchers analyzed blood and urine samples to demonstrate that people with the NOS2 polymorphism had higher levels of nitric oxide.

Weinberg said they believe that evolution has favored this protective mechanism for individuals who are most often exposed to malaria. Not surprisingly, then, Caucasians do not possess this genetic mutation, so they are at much higher risk for severe malaria. While malaria is seemingly a remote possibility in the heartland of America, the disease was once prevalent in the parts of the U.S. It was virtually eliminated by the 1940s through better mosquito control and improved living conditions, yet the disease periodically emerges in the U.S., even today.

Only about 1,200 malaria cases are reported in the U.S. yearly, and it is unlikely to ever reach epidemic proportions here, but malaria is rampant in much of Africa and Asia, infecting about 500 million people each year. Despite some advances in treatment, malaria continues to be deadly -- a malaria death occurs every 30 seconds worldwide.

Many of those infected with the malaria parasite may have no symptoms or only mild flu-like symptoms. However, others progress to more severe disease with extreme fatigue, fever, and chills. A third of these victims with severe disease -- mostly children and pregnant women -- succumb to more deadly consequences, either cerebral malaria or severe anemia.

In cerebral malaria, red blood cells containing the malaria parasite stick to the lining of blood vessels, causing blockages and decreasing blood supply to parts of the brain. Up to one-third of children with cerebral malaria die despite treatment. In severe anemia, parasites gobble up hemoglobin, destroy red blood cells and block blood formation until the patient is beyond rescue. Even with the best of current treatments, more than 1 million people die each year of severe malaria. The newly identified NOS2 gene polymorphism -- called C-1173T NOS2 -- protects against both kinds of malaria.

In addition to investigators from Duke, Utah, Australia and the CDC, researchers from the Hubert Kairuki Memorial University in Tanzania, and the World Health Organization in Switzerland contributed to the work. The research was supported by the National Institutes of Health, the U.S. Veterans Affairs, the U.S. Agency for International Development and the U.S. Centers for Disease Control and Prevention.

Rebecca Levine | EurekAlert!
Further information:
http://dukemednews.org/news/article.php?id=6008
http://www.mc.duke.edu/

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

An MRI technique has been developed to improve the detection of tumors

03.06.2020 | Medical Engineering

K-State study reveals asymmetry in spin directions of galaxies

03.06.2020 | Physics and Astronomy

The cascade to criticality

03.06.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>